Cipher Pharma (CPHR) Misses Q1 EPS by 6c

Cipher Pharma (NASDAQ: CPHR) reported Q1 EPS of ($0.10), $0.06 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $9.1 million versus the consensus estimate of $10.72 million.

For earnings history and earnings-related data on Cipher Pharma (CPHR) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• XP Inc eyes US banking license as next business step
• Four Tree Island Advisory calls DoubleDown $11.25 offer too low